Apollo Biotech Co., Ltd.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
Assaya provides affordable and equitable human error reducing diagnostics at scale, with real-time reporting. Our mission is to provide the world with reliable, augmented, practical, and inexpensive diagnostics (RAPID) that can be deployed anywhere, anyti
The content above was translated by Ai
Founded Year
2020
Unified Business No.
83123696
Status
Active
Number of Employees
0
Total Paid-in
Capital
500,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Assaya is a medical technology company that is revolutionizing the way rapid diagnostics are conducted and interpreted. The company's flagship products, the iaX Universal Rapid Diagnostic Reader and LEIQA RDTs, offer a number of advantages over traditional rapid diagnostic tests, including:
The content above was translated by Ai
